Eli Lilly and Company (LLY) gained 0.58% in Thursday's session, pushing shares to $1,288.93 and extending a steady climb that has characterized the stock over recent weeks.
Over the past seven days, LLY has advanced 1.32%, while the 30-day window shows a more substantial gain of 8.68%, reflecting sustained buying interest in the pharmaceutical giant.
The company's market capitalization stood at $1,142.64 billion as of October 29, 2026, cementing Eli Lilly's position among the largest publicly traded companies by that measure.
The session's modest gain added to a broader pattern of strength for the stock, with the 30-day performance representing one of the more notable moves in the timeframe tracked.
